Physician profile
Christopher A Cederberg
NPI 1982791703
$2,859.01
in general payments reported to CMS, 2019-2025
19 companies · $768 in 2025
The $768 reported for 2025 was more than what a typical Otolaryngology provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $486 · 2020: $85.71 · 2021: $156 · 2022: $343 · 2023: $369 · 2024: $652 · 2025: $768.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,789.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,789.07 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genzyme Corporation | $1,139.39 | 2019-2025 | |
| Glaxosmithkline, LLC. | $413.82 | 2021-2025 | Nucala |
| Abbvie INC. | $229.70 | 2021-2025 | Qulipta |
| Regeneron Healthcare Solutions, INC. | $186.14 | 2024-2025 | Dupixent |
| Intersect Ent, INC. | $167.97 | 2019-2022 | |
| Aerin Medical INC. | $145.54 | 2024-2025 | |
| Optinose US, INC. | $124.09 | 2019-2023 | |
| Medtronic USA, INC. | $76.76 | 2019 | |
| Acclarent, INC | $61.91 | 2019-2023 | Relieva Tract, Acclarent Aera |
| Alk-Abello, INC | $58.88 | 2019-2022 | |
| Novartis Pharmaceuticals Corporation | $46.90 | 2019-2025 | |
| Pharming Healthcare, INC. | $44.59 | 2022-2023 | Ruconest |
| Davol INC. | $41.32 | 2020 | |
| Integra Lifesciences Corporation | $39.41 | 2024-2025 | Trudi Probe, Relieva Spinplus Nav, Inspira Air |
| Amgen INC. | $21.72 | 2025 | Tezspire |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $18.85 | 2024 | Tula |
| Stryker Corporation | $17.84 | 2022 | |
| Merck Sharp & Dohme LLC | $13.03 | 2023 | |
| Genentech USA, INC. | $11.15 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Cederberg listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.